Navigation Links
NameProtect sold, tech entrepreneur to focus on Jellyfish.com

Madison, Wis. - Now that two companies he once owned have been sold, and he's working on another exit strategy, Brian Wiegand's days as a self-described serial entrepreneur might be over.

Wiegand's second company, the Madison-based NameProtect, a developer of digital brand management services, has been sold to

Source:wistechnology.com By Joe Vanden Plas 03/23/07


Related biology technology :

1. Delaware company will keep NameProtect here
2. NameProtect releases annual list of top trademarkers
3. Fiserv/CUNA Mutual; Esker; NameProtect
4. NameProtect partners with Oregon firm to boost fraud detection
5. NameProtect roots out fake tsunami-related donation sites
6. NameProtect study shows 92% of top brands losing out on search engines
7. NameProtect announces Web-enhanced trademark software
8. NameProtect and MasterCard unite to combat online fraud, phishing
9. NameProtects watchdog tool keeps eye on search-engine ads
10. Tapping the value of entrepreneurial advisors
11. Kauffman study shows consistent entrepreneurial growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):